3032 related articles for article (PubMed ID: 8542927)
1. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
3. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
4. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
Reid CD; Stackpoole A; Meager A; Tikerpae J
J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.
Wang CQ; Udupa KB; Lipschitz DA
J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445
[TBL] [Abstract][Full Text] [Related]
6. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
7. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
11. In vitro response of T cells from aplastic anemia patients to antilymphocyte globulin and phytohemagglutinin: colony-stimulating activity and lymphokine production.
Tong J; Bacigalupo A; Piaggio G; Figari O; Sogno G; Marmont A
Exp Hematol; 1991 Jun; 19(5):312-6. PubMed ID: 1902792
[TBL] [Abstract][Full Text] [Related]
12. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies.
Hanenberg H; Dilloo D; Laws HJ; Zessack N; Heyll A; Burdach S
Exp Hematol; 1995 Dec; 23(14):1543-52. PubMed ID: 8542945
[TBL] [Abstract][Full Text] [Related]
13. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
14. Cytokine production in long-term marrow cultures after autologous bone marrow transplantation.
Roingeard F; Domenech J; Dayan A; Gihana E; Colombat P; Binet C
Bone Marrow Transplant; 1995 May; 15(5):741-7. PubMed ID: 7545488
[TBL] [Abstract][Full Text] [Related]
15. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
Misago M; Chiba S; Kikuchi M; Tsukada J; Sato T; Oda S; Eto S
Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
Murphy M; Perussia B; Trinchieri G
Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270
[TBL] [Abstract][Full Text] [Related]
18. Influence of T-lymphocytes and lactoferrin on the survival-promoting effects of IL-1 and IL-6 on human bone marrow granulocyte-macrophage and erythroid progenitor cells.
Hangoc G; Falkenburg JH; Broxmeyer HE
Exp Hematol; 1991 Aug; 19(7):697-703. PubMed ID: 1893956
[TBL] [Abstract][Full Text] [Related]
19. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth.
Barak Y; Hahn T; Pecht M; Karov Y; Berrebi A; Zaizov R; Stark B; Buchner V; Burstein Y; Trainin N
Exp Hematol; 1992 Feb; 20(2):173-7. PubMed ID: 1544385
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human granulocyte-macrophage colony formation by interleukin 2-treated lymphocytes is mediated by interferon gamma and tumor necrosis factor alpha.
Takahashi M; Oshimi K; Mizoguchi H
Exp Hematol; 1990 Jun; 18(5):395-9. PubMed ID: 2110909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
